Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation
This article is from
The Cancer Letter
archive.
Vol. 35 No. 15 | April 17, 2009
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
NCI Encourages IP Chemo For Stage III Ovarian Cancer
January 27, 2006
TCL Archive
Agreement Nears On New Guidelines For Center Grants
November 14, 1980
TCL Archive
Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer
May 27, 2005
TCL Archive
Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research
August 5, 2011
TCL Archive
Consensus Conference Suggest Research Required For Advances In Pain Control
May 30, 1986
TCL Archive
Alternative Medicine Officer Awards 30 Research Grants
October 15, 1993
